The present invention relates to recombinant anti-Nipah virus vaccines and theadministration of such vaccines to animals, advantageously pigs.Advantageously, the anti- Nipah virus vaccine may comprise a recombinantavipox virus containing a Nipah virus glycoprotein gene. The inventionencompasses methods of vaccinating animals, advantageously pigs, byadministration of anti-Nipah virus vaccines that may comprise a recombinantavipox virus that may contain a Nipah virus glycoprotein gene.
